The interaction of factor V and tissue factor pathway inhibitor in a myeloma patient with acquired factor V deficiency-Reference-Cited by-同舟云学术

The interaction of factor V and tissue factor pathway inhibitor in a myeloma patient with acquired factor V deficiency

Author:

De Maertelaere E.¹^ORCID,Castoldi E.²,Van haute I.¹,Deeren D.³,Devreese K. M.⁴

Affiliation:

1. Clinical Laboratory; AZ Delta Hospital; Roeselare Belgium

2. Department of Biochemistry; Cardiovascular Research Institute Maastricht; Maastricht University; Maastricht the Netherlands

3. Clinical Haematology; AZ Delta Hospital; Roeselare Belgium

4. Coagulation Laboratory; Department of Clinical Chemistry, Microbiology and Immunology; Ghent University Hospital; Ghent Belgium

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

Reference12 articles.

5. Isolated decrease of factor v in children treated by 6-mercaptopurine for acute lymphoblastic leukemia;Filhon;J Thromb Haemost,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Factor V variants in bleeding and thrombosis;Research and Practice in Thrombosis and Haemostasis;2024-01